Latest Insights
When the Playbook Stops Working: What the ECB’s Dilemma Reveals About Europe’s Ageing Economy and the Women’s Health Opportunity
Europe's central banks are confronting inflation driven by geopolitics, ageing populations and structural change rather than traditional demand cycles....
Gilead’s $11.5B Bet: What Two Companies Saw in One Week
Gilead and UCB deployed $3B+ on similar autoimmune drugs within days. What this pharmaceutical investment convergence signals for institutional...
Is Women’s Health a Good Investment Opportunity for Private Wealth?
$124 trillion is transferring to women. Women's health receives 6% of healthcare investment. These are not two separate facts....
Latest Insights
When the Playbook Stops Working: What the ECB’s Dilemma Reveals About Europe’s Ageing Economy and the Women’s Health Opportunity
Europe's central banks are confronting inflation driven by geopolitics, ageing populations and structural change rather than traditional demand cycles....
Gilead’s $11.5B Bet: What Two Companies Saw in One Week
Gilead and UCB deployed $3B+ on similar autoimmune drugs within days. What this pharmaceutical investment convergence signals for institutional...
Is Women’s Health a Good Investment Opportunity for Private Wealth?
$124 trillion is transferring to women. Women's health receives 6% of healthcare investment. These are not two separate facts....